Literature DB >> 11222350

The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

G B Arden1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222350      PMCID: PMC1723904          DOI: 10.1136/bjo.85.3.366

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  87 in total

1.  A mutation in NRL is associated with autosomal dominant retinitis pigmentosa.

Authors:  D A Bessant; A M Payne; K P Mitton; Q L Wang; P K Swain; C Plant; A C Bird; D J Zack; A Swaroop; S S Bhattacharya
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

2.  I. Impaired dark adaptation in symptomatic carotid artery disease.

Authors:  U Havelius; D Bergqvist; P Falke; B Hindfelt; T Krakau
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

Review 3.  A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?

Authors:  B Williams
Journal:  Miner Electrolyte Metab       Date:  1998

4.  VEGF increases retinal vascular ICAM-1 expression in vivo.

Authors:  M Lu; V L Perez; N Ma; K Miyamoto; H B Peng; J K Liao; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

5.  Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity.

Authors:  A R Janecke; M Meins; M Sadeghi; K Grundmann; E Apfelstedt-Sylla; E Zrenner; T Rosenberg; A Gal
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

6.  II. Improved dark adaptation after carotid endarterectomy. Evidence of a long-term ischemic penumbra?

Authors:  U Havelius; D Bergqvist; B Hindfelt; T Krakau
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

7.  Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.

Authors:  M K Mathews; C Merges; D S McLeod; G A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-12       Impact factor: 4.799

8.  Molecular genetic study of autosomal dominant retinitis pigmentosa in Lithuanian patients.

Authors:  V Kucinskas; A M Payne; D Ambrasiene; V Jurgelevicius; D Steponaviciūte; J V Arciuliene; E Daktaraviciene; S Bhattacharya
Journal:  Hum Hered       Date:  1999-03       Impact factor: 0.444

9.  Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa.

Authors:  M Buraczynska; W Wu; R Fujita; K Buraczynska; E Phelps; S Andréasson; J Bennett; D G Birch; G A Fishman; D R Hoffman; G Inana; S G Jacobson; M A Musarella; P A Sieving; A Swaroop
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

10.  X-linked retinitis pigmentosa in two families with a missense mutation in the RPGR gene and putative change of glycine to valine at codon 60.

Authors:  G A Fishman; S Grover; S G Jacobson; K R Alexander; D J Derlacki; W Wu; M Buraczynska; A Swaroop
Journal:  Ophthalmology       Date:  1998-12       Impact factor: 12.079

View more
  52 in total

Review 1.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

2.  Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Authors:  Goutham R Adelli; Tushar Hingorani; Nagendra Punyamurthula; Sai Prachetan Balguri; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2015-02-26       Impact factor: 5.571

3.  Cystoid macular edema related to diabetic retinopathy with retinitis pigmentosa.

Authors:  Kazuki Hotta; Junko Hotta
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

Review 4.  Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.

Authors:  Timothy S Kern; David A Antonetti; Lois E H Smith
Journal:  Ophthalmic Res       Date:  2019-07-30       Impact factor: 2.892

5.  Novel findings in enhanced S-cone syndrome: a case with macular retinal neovascularization and severe retinal vasculitis.

Authors:  Fatemeh Bazvand; Hasan Khojasteh; Mohammad Zarei
Journal:  Doc Ophthalmol       Date:  2019-07-10       Impact factor: 2.379

Review 6.  Do photoreceptor cells cause the development of retinal vascular disease?

Authors:  Timothy S Kern
Journal:  Vision Res       Date:  2017-05-08       Impact factor: 1.886

Review 7.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 8.  Spare the rods and spoil the retina: revisited.

Authors:  S Sivaprasad; G Arden
Journal:  Eye (Lond)       Date:  2015-12-11       Impact factor: 3.775

9.  Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2007-12-22       Impact factor: 2.031

10.  Combined occurrence of diabetes mellitus and retinitis pigmentosa.

Authors:  Afaf Al-Adsani; Fadl Abdel Gader
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.